Nestlé Health Science to acquire Aimmune in US$2.6 billion move

The aim is to boost Nestlé Health Science’s food allergy treatment foothold

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Dietary allergies can have fatal consequences, even though they are usually experienced with mild symptoms. Scientists’ experiments with the format of butyrate... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé’s Nutrition & Health Science marked a CHF 7.7 billion (US$8 billion) sales growth in the first half of the year, the company’s latest... Read More

FormattedPicture

BUSINESS NEWS

Nestlé Health Science is set to acquire The Better Health Company (TBHC), as part of its goals to grow global market share while spurring innovation across the... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

A US study suggests that people with physician-diagnosed food allergies are less likely to become infected with SARS-CoV-2, the virus that causes COVID-19.Without easy... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé Health Science is set to acquire Brazil-based Puravida, expanding its presence across the vitamins, minerals, herbals and supplements segment.

trans